What's new

EMEA-003426-PIP01-23

EMEA-003426-PIP01-23

Mar 18, 2025 - 11:57
 0
EMEA-003426-PIP01-23
EMEA-003426-PIP01-23
Read More

Tags:

Previous Article

Clario continues acquisition spree with imaging specialist NeuroRx

Next Article

Tayu: from trepidation to triumph

Related Posts

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Clinical investigation of medicinal products in the treatment of epileptic disorders - Scientific guideline

Clinical investigation of medicinal products in the tre...

Mar 12, 2025  0

Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 February 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025 to 13 February 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 10 ...

Feb 10, 2025  0